Procyon Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
26,894
-1,529
| -5% | -$70.8K | 0.12% | 161 |
|
|
2025
Q1 | $1.73M | Buy |
28,423
+9,763
| +52% | +$595K | 0.1% | 192 |
|
|
2024
Q4 | $1.06M | Buy |
18,660
+1,423
| +8% | +$80.5K | 0.07% | 229 |
|
|
2024
Q3 | $891K | Buy |
17,237
+572
| +3% | +$29.6K | 0.06% | 249 |
|
|
2024
Q2 | $692K | Buy |
16,665
+1,858
| +13% | +$77.2K | 0.05% | 269 |
|
|
2024
Q1 | $803K | Buy |
14,807
+5,595
| +61% | +$303K | 0.06% | 253 |
|
|
2023
Q4 | $473K | Sell |
9,212
-4,350
| -32% | -$223K | 0.04% | 323 |
|
|
2023
Q3 | $787K | Buy |
13,562
+2,135
| +19% | +$124K | 0.08% | 224 |
|
|
2023
Q2 | $731K | Buy |
11,427
+1,487
| +15% | +$95.1K | 0.09% | 207 |
|
|
2023
Q1 | $689K | Sell |
9,940
-645
| -6% | -$44.7K | 0.11% | 172 |
|
|
2022
Q4 | $762K | Buy |
10,585
+1,365
| +15% | +$98.2K | 0.14% | 152 |
|
|
2022
Q3 | $655K | Sell |
9,220
-2,756
| -23% | -$196K | 0.16% | 127 |
|
|
2022
Q2 | $922K | Sell |
11,976
-3,646
| -23% | -$281K | 0.2% | 106 |
|
|
2022
Q1 | $1.14M | Buy |
15,622
+4,946
| +46% | +$361K | 0.24% | 91 |
|
|
2021
Q4 | $666K | Buy |
10,676
+5,548
| +108% | +$346K | 0.14% | 141 |
|
|
2021
Q3 | $303K | Buy |
5,128
+61
| +1% | +$3.6K | 0.08% | 227 |
|
|
2021
Q2 | $339K | Sell |
5,067
-676
| -12% | -$45.2K | 0.09% | 190 |
|
|
2021
Q1 | $363K | Sell |
5,743
-298
| -5% | -$18.8K | 0.16% | 141 |
|
|
2020
Q4 | $375K | Sell |
6,041
-118
| -2% | -$7.33K | 0.18% | 130 |
|
|
2020
Q3 | $371K | Buy |
6,159
+21
| +0.3% | +$1.27K | 0.21% | 112 |
|
|
2020
Q2 | $361K | Buy |
6,138
+357
| +6% | +$21K | 0.19% | 109 |
|
|
2020
Q1 | $322K | Sell |
5,781
-43
| -0.7% | -$2.4K | 0.21% | 99 |
|
|
2019
Q4 | $374K | Buy |
+5,824
| New | +$374K | 0.23% | 96 |
|